Search

Robert A Peura

from Princeton, MA
Age ~82

Robert Peura Phones & Addresses

  • 80 Calamint Hill Rd, Princeton, MA 01541 (508) 464-5683 (978) 464-2932 (978) 464-5683
  • 11 Myober Ln, Edgartown, MA 02539 (508) 627-7684
  • Colorado Springs, CO
  • Adah, PA
  • West Boylston, MA
  • Richmond, VT
  • Lacon, IL
  • Saint Paul, MN
  • 80 Calamint Hill Rd S, Princeton, MA 01541 (978) 479-7950

Work

Company: Vivascan corp Address: 560 Prospect St, Oakdale, MA 01583 Phones: (508) 852-1600 Position: Manager Industries: Noncommercial Research Organizations

Education

Degree: High school graduate or higher

Business Records

Name / Title
Company / Classification
Phones & Addresses
Robert Peura
Manager
Vivascan Corp
Noncommercial Research Organizations
560 Prospect St, Oakdale, MA 01583
Website: vivascan.com
Robert Peura
Manager
Vivascan Corp
Noncommercial Research Organizations
560 Prospect St, Oakdale, MA 01583
Website: vivascan.com
Robert Peura
Manager
Vivascan Corp
Research & Development in Biotechnology
560 Prospect St, West Boylston, MA 01583
(508) 852-1600

Publications

Isbn (Books And Publications)

Medical Instrumentation: Application and Design

View page
Author

Robert A. Peura

ISBN #

0471153680

Us Patents

Non-Invasive Substance Concentration Measurement Using And Optical Bridge

View page
US Patent:
7003337, Feb 21, 2006
Filed:
Apr 26, 2002
Appl. No.:
10/134310
Inventors:
Hannu Harjunmaa - Holden MA, US
Stevan Kun - Worcester MA, US
Robert A. Peura - Princeton MA, US
John A. Rolls - Armonk NY, US
Assignee:
VivaScan Corporation - West Boylston MA
International Classification:
A61B 5/00
US Classification:
600316, 600322, 600310
Abstract:
An improved method for non-invasively measuring a concentration of a target analyte dissolved in a fluid flowing through a sample is presented. It includes directing a probe beam of electromagnetic radiation, consisting of time multiplexed components of different wavelengths, through the sample and measuring the difference of the absorption of the radiation at at least one wavelength pair at different sample states. During sample state changes, the amount of fluid containing the target analyte within the sample is changing, which varies the total amount of target analyte in the sample, as well as the absorption properties of the sample. The sample states are produced, for instance, by compressing and uncompressing the tissue sample. The accuracy of the presented method is enhanced by including continuous estimation of the amount of the fluid containing the target analyte within the sample, and measurement of the variations of the absorption at a wavelength at which the target analyte absorbs significantly. The method is particularly useful in measuring the concentration of a target analyte, such as glucose, in tissue containing blood.

Impedance Spectroscopy System For Ischemia Monitoring And Detection

View page
US Patent:
58072721, Sep 15, 1998
Filed:
Oct 30, 1996
Appl. No.:
8/739162
Inventors:
Steven Kun - Worcester MA
Robert A. Peura - Princeton MA
Borislav Ristic - Worcester MA
Assignee:
Worcester Polytechnic Institute - Worcester MA
International Classification:
A61B 504
US Classification:
600547
Abstract:
An impedance spectroscopy tissue status monitoring and measurement system is disclosed. The system uses a synthesizer to generates electrical signals of selected frequencies. An electrical current source is responsive to the synthesizer and generates electrical currents for transmission through tissue. Electrodes or inductive coils of the system apply the electrical current to the tissue and sense voltages generated in the tissue in response to the electrical current. A controller determines the spectral response of the tissue by detecting magnitude and phase information of the electrical energy transmitted through the tissue. The information is then used to determine volumes of compartments within the tissue and ionic concentrations of compartmental fluids. Capacitive effects derived from the phase information are used to determine cell membrane functionality within the tissue. From this analysis, status, specifically, ischemia, may be determined on an absolute basis.

Method And Apparatus For Monitoring Blood Analytes Noninvasively By Pulsatile Photoplethysmography

View page
US Patent:
51370239, Aug 11, 1992
Filed:
Apr 19, 1990
Appl. No.:
7/511229
Inventors:
Yitzhak Mendelson - Worcester MA
Robert A. Peura - Princeton MA
Hannu Harjunmaa - Vessy, CH
Assignee:
Worcester Polytechnic Institute - Worcester MA
International Classification:
A61B 500
US Classification:
128633
Abstract:
A non-invasive system for measuring the concentration of an analyte, such as glucose, in an absorbing matrix is described. The system directs beams of light at the matrix using an analyte sensitive wavelength and an analyte insensitive wavelength. The principles of photoplethysmography are applied to measure the change in light intensity caused by matrix absorption before and after the blood volume change caused by the systolic phase of the cardiac cycle. The change in light intensity is converted to an electrical signal which is used to adjust the light intensity and as a measure of analyte concentration.

Method And Apparatus For Measuring The Concentration Of Absorbing Substances

View page
US Patent:
51121247, May 12, 1992
Filed:
Apr 19, 1990
Appl. No.:
7/511341
Inventors:
Hannu Harjunmaa - Vessy, CH
Robert A. Peura - Princeton MA
Yitzhak Mendelson - Worcester MA
Assignee:
Worcester Polytechnic Institute - Worcester MA
International Classification:
G01N 2159
G01N 3349
US Classification:
356 39
Abstract:
A non-invasive system for measuring the concentration of an analyte in an absorbing matrix is described. The system directs a beam of radiation at the matrix. The beam consists of a series of successive alternate pulses of electro-magnetic radiation, one of which is highly absorbed by the analyte and the other of which is non-absorbed. The transmitted or reflected beam is optically detected and an electrical signal proportional to beam intensity is used to adjust the beam intensity and as a measure of analyte concentration.

Miniature Pco.sub.2 Probe For In Vivo Biomedical Applications

View page
US Patent:
51580837, Oct 27, 1992
Filed:
Oct 23, 1989
Appl. No.:
7/425490
Inventors:
Emilio Sacristan - Worcester MA
Albert Shahnarian - Princeton MA
Robert A. Peura - Princeton MA
Assignee:
Mountpelier Investments, S.A. - Vaduz
International Classification:
A61B 500
US Classification:
128635
Abstract:
The pCO. sub. 2 probe has a miniaturized glass bulb pH sensor concentrically arranged in a flexible, noncollapsible hollow tube. A silicone end cap is expanded in a freon solvent and placed over the end of the tube while the freon evaporates, returning the end cap to its normal contracted size where it forms a tight elastic fit. The pH sensor includes an internal electrode and an outer electrode is concentrically wrapped about the glass bulb so the electrodes are in close proximity. The glass bulb and the chamber defined by the tube walls and silicone membrane are both filled with suitable electrolytes of sufficient volume to minimize air bubbles. Without air bubbles, the electrodes remain emersed in the respective electrolytes regardless of the physical orientation of the probe.

Method And Device For Eliminating Electrode Drift

View page
US Patent:
57664323, Jun 16, 1998
Filed:
Apr 17, 1996
Appl. No.:
8/632330
Inventors:
Raymond M. Dunn - Shrewsbury MA
Robert Harrington - Westboro MA
Robert Peura - Princeton MA
Stevan Kun - Worcester MA
Assignee:
University of Massachusetts - Boston MA
Worcester Polytechnic Institute - Worcester MA
International Classification:
G01N 2726
US Classification:
204412
Abstract:
A pH-measuring method and device for monitoring and then correcting for electrode drift is provided. The device includes a pH-measuring electrode and more than one reference electrode. During operation, the pH-measuring device is place in contact with a sample. The pH value measured at each electrode pair is due to the electrical potential difference between the pH electrode and the reference electrode. The maximum and minimum pH values are determined, and then the remaining pH values are averaged together to generate an overall average pH. The maximum and minimum pH values are subtracted from the average pH to generate a difference which is then compared to a user-defined drift level to determine if a particular electrode is deficient. The pH values from deficient electrodes are not considered when the overall pH of the sample is determined.
Robert A Peura from Princeton, MA, age ~82 Get Report